Randomised, phase 1, dose-finding study of MEDI416...
Dose-finding study: PCK9 MAb/GLP-1 analogue fusion molecule
GPCRs
Kinetic and system bias as drivers of metabotropic...
mGluR5 Negative Allosteric Modulators (NAMs) at a glance
Analgesic and anti-inflammatory properties of nove...
A specific new EP4 receptor antagonist for Rheumatoid Arthritis
A Novel Interacting Protein SERP1 Regulates the N-...
SERP1: a new GLP-1 receptor interactor
Second messenger assays bring clarity to cardiovas...
GPCR-specific assays measure second messengers to advance cardiovascular...
Identification of 4-phenylquinolin-2(1H)-one as a ...
New allosteric inhibitor of AKT targets its PH domain
New partnership with Excellerate Bioscience
Excellerate Bioscience and Cisbio announce the launch of a collaboration...
6-Hydroxy-5,7-dimethoxy-flavone suppresses the neu...
A natural product opens new doors for treating chronic lung inflammation
Distinct role of PLCbeta3 in VEGF-mediated directi...
Cisbio IP1 ELISA used to measure the lipase activity